Gabather AB (publ) (STO:GABA)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.0448
+0.0012 (2.75%)
Aug 25, 2025, 2:13 PM CET
2.75%
Market Cap10.30M
Revenue (ttm)n/a
Net Income (ttm)-4.91M
Shares Out236.20M
EPS (ttm)-0.20
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume162,708
Average Volume902,664
Open0.0458
Previous Close0.0436
Day's Range0.0422 - 0.0470
52-Week Range0.0278 - 0.8180
Beta-0.19
RSI42.61
Earnings DateAug 25, 2025

About Gabather AB

Gabather AB (publ), a pharmaceutical company, researches and develops drug candidates for the treatment of central nervous system diseases. It offers drugs primarily in the areas of anti-psychotics; anti-depressants and anxiolytics; analgesics; and cognition-enhancing treatments, including Alzheimer’s disease. The company develops GT-002 for the treatment of schizophrenia, major depressive disorder, orphan drug, and alzheimer´s disease. It has a collaborative agreement with the Centre for Neuropsychiatric Schizophrenia Research at the Psychiatr... [Read more]

Sector Healthcare
Founded 2014
Employees 3
Stock Exchange Nasdaq Stockholm
Ticker Symbol GABA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.